GUIDED THERAPEUTICS INC (GTHP) › RevenueGUIDED THERAPEUTICS INC (GTHP) — RevenueAnnual figures by period end, from SEC filings.2010-12-31: $3.36M2011-12-31: $3.60M2012-12-31: $3.34M2013-12-31: $820.0K2014-12-31: $65.0K2015-12-31: $42.0K2016-12-31: $02017-12-31: $244.0K2018-12-31: $57.0K2019-12-31: $36.0K2020-12-31: $102.0K2021-12-31: $81.0K2022-12-31: $13.0K2023-12-31: $98.0K2024-12-31: $7.0K2025-12-31: $767.0K$767.0K2010-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$767.0K+10857.1%2026-03-31From 2025-01-012024-12-31$7.0K-92.9%2026-03-31From 2024-01-012023-12-31$98.0K+653.8%2025-03-31From 2023-01-012022-12-31$13.0K-84.0%2024-03-28From 2022-01-012021-12-31$81.0K-20.6%2023-03-30From 2021-01-012020-12-31$102.0K+183.3%2022-03-30From 2020-01-012019-12-31$36.0K-36.8%2021-04-07From 2019-01-012018-12-31$57.0K-76.6%2020-04-20From 2018-01-012017-12-31$244.0K—2019-05-08From 2017-01-012016-12-31$0-100.0%2017-03-22From 2016-01-012015-12-31$42.0K-35.4%2017-03-22From 2015-01-012014-12-31$65.0K-92.1%2016-03-15From 2014-01-012013-12-31$820.0K-75.4%2015-03-25From 2013-01-012012-12-31$3.34M-7.2%2014-03-26From 2012-01-012011-12-31$3.60M+6.9%2013-03-27From 2011-01-012010-12-31$3.36M—2012-03-28From 2010-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)